Antiviral effect – Page 7 – Communicable Diseases Research

Computer Aided Drug Design Approach to Screen Phytoconstituents of Adhatoda vasica as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme

Article

Published on 2022-02-202022-10-29
Journal: International Review of Cell and Molecular Biology [Category] COVID-19,

High-Sulfated Glycosaminoglycans Prevent Coronavirus Replication

Article

Published on 2022-02-172022-10-28
Journal: Viruses [Category] COVID-19, COVID19(2023년), Fulltext, MERS, SARS,

Biodegradable Nanohybrid Materials as Candidates for Self-Sanitizing Filters Aimed at Protection from SARS-CoV-2 in Public Areas

공공 장소에서 SARS-CoV-2로부터 보호하기 위한 자체 소독 필터의 후보로서의 생분해성 나노하이브리드 재료

Article

Published on 2022-02-162022-09-10
Journal: Molecules [Category] COVID19(2023년), MERS, SARS, 치료제,

In Silico Analysis and Synthesis of Nafamostat Derivatives and Evaluation of Their Anti-SARS-CoV-2 Activity

Brief Report

Published on 2022-02-142022-10-28
Journal: Viruses [Category] COVID-19, COVID19(2023년), SARS,

Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs

Article

Published on 2022-02-132022-10-29
Journal: International Journal of Molecular Sciences [Category] COVID-19, COVID19(2023년), SARS,

[키워드] activity addition Amphibian AMPs analyzed antimicrobial antimicrobial peptide antimicrobial peptides Antiviral antiviral activity antiviral agent Antiviral effect antiviral therapy Compound Coronaviruses COVID-19 pandemic cytotoxicity demonstrated DNA and RNA drug drug resistance evaluated evidenced frog peptides Glutamine Gram-negative bacteria help herpesviruses HSV-1 Influenza virus inhibit inhibition activity MOST overcome peptide peptides previous study Pro proline reduced replaced Replication rising SARS-CoV-2 selective Temporin temporins Therapeutic molecule therapeutic option Threats viral family virus Virus-host interaction viruses widespread
[DOI] 10.3390/ijms23042060 PMC 바로가기 [Article Type] Article

Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses

Article

Published on 2022-02-102022-10-29
Journal: Journal of the American Chemical Society [Category] COVID-19, COVID19(2023년), SARS,

Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?

Perspective

Published on 2022-02-092022-10-27
Journal: Antibiotics [Category] COVID-19,

The nanocomposites designs of phytomolecules from medicinal and aromatic plants: promising anticancer-antiviral applications

Review

Published on 2022-01-292022-10-28
Journal: Beni-Suef University Journal of Basic and Applied Sciences [Category] COVID-19,

A Natural Plant Source-Tea Polyphenols, a Potential Drug for Improving Immunity and Combating Virus

Review

Published on 2022-01-272022-10-30
Journal: Nutrients [Category] COVID-19,

Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation

계산 우선 순위 화 약물은 SARS-COV-2 감염 및 Syncytia 형성을 억제합니다

Case Study

Published on 2022-01-272022-09-10
Journal: Briefings in Bioinformatics [Category] 변종, 신약개발, 치료제,